ISSN 1006-298X      CN 32-1425/R

导航

肾脏病与透析肾移植杂志 ›› 2023, Vol. 32 ›› Issue (2): 179-183.DOI: 10.3969/j.issn.1006-298X.2023.02.016

• • 上一篇    下一篇

具有肾脏意义的单克隆免疫球蛋白病诊治进展

杜静雪, 胡章学   

  • 出版日期:2023-04-28 发布日期:2023-04-24

Advances in diagnosis and treatment of monoclonal gammopathy of renal significance

DU Jingxue, HU Zhangxue   

  • Online:2023-04-28 Published:2023-04-24

摘要: 与意义不明的单克隆免疫球蛋白病(MGUS)不同,具有肾脏意义的单克隆免疫球蛋白病(MGRS)产生的肾毒性单克隆蛋白,可造成肾脏等脏器的不可逆性损伤,即使在肾移植术后也具有较高复发率。因此早期识别MGRS并开展靶向恶性增殖灶(B细胞/浆细胞性)的疗法,对于挽救脏器功能,改善预后具有重要意义。


关键词: 具有肾脏意义的单克隆免疫球蛋白病, 临床病理特征, 诊断, 治疗

Abstract: Monoclonal gammopathy of renal significance (MGRS) is different from monoclonal gammopathy of undetermined significance (MGUS). Nephrotoxic monoclonal immunoglobulins produced by MGRS cause irreversible damage to human organs, especially kidneys. There is a high recurrence rate in MGRS patients after renal transplantation. Therefore, early identification of MGRS and treatments targeting malignant proliferative foci (B cell/plasma cell) are of great significance for saving organ function and improving prognosis.


Key words: monoclonal gammopathy of renal significance, clinicopathological features, diagnosistreatment